Loading...
Treatment of Hepatitis C Post-Liver Transplantation Could Mitigate Discard Rates of Hepatitis C-Positive Deceased Donor Livers and Expand the Donor Pool
BACKGROUND: Prior to 2014, treatment for hepatitis C was limited. However, the subsequent introduction of direct acting antiviral medications (DAA) against hepatitis C led to improvements in morbidity and better medication tolerance. DAA therapy allowed for an increase in treatment rates of hepatiti...
Na minha lista:
| Udgivet i: | J Transplant |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850848/ https://ncbi.nlm.nih.gov/pubmed/33564467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6612453 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|